Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Leonard Resignation Leaves AAM Looking For New Leadership
Gaugh Steps In As Interim CEO Of US Generics And Biosimilars Association
Dec 06 2022
•
By
Dave Wallace
As interim CEO, David Gaugh has replaced Dan Leonard • Source: Shutterstock
More from Leadership
More from Generics Bulletin